USPSTF: Ovarian cancer screen to be avoided for most women

July 20, 2017

(HealthDay)—The potential harms of ovarian cancer screening outweigh the benefits, so only very specific groups of women should be screened for the disease, the U.S. Preventive Services Task Force (USPSTF) says in a draft recommendation.

The new guidance reaffirms a 2012 final recommendation made by the Task Force. The USPSTF noted that no other major medical organization recommends screening for ovarian cancer among women in the general population.

"The found that screening women without signs or symptoms for ovarian cancer does not decrease the number of deaths from the disease, and may lead to ," Task Force member Maureen Phipps, M.D., M.P.H., said in a USPSTF news release. "Therefore, the Task Force recommends against screening for ovarian cancer in women who have no signs or symptoms, and who are not at high risk for ."

The draft recommendation statement and draft evidence review are posted for public comment on the Task Force website. Comments can be submitted from July 18 through Aug. 14.

Explore further: Hormone therapy not advised for preventing disease after menopause

More information: Evidence Review
Draft Recommendation Statement
Comment on Recommendation Statement

Related Stories

Hormone therapy not advised for preventing disease after menopause

May 17, 2017
(HealthDay)—Using hormone therapy to prevent chronic health issues, such as heart disease and bone loss, in postmenopausal women may do more harm than good, the U.S. Preventive Services Task Force (USPSTF) says.

USPSTF: evidence lacking for pelvic screening examinations

June 29, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to weigh the balance of benefits and harms for screening pelvic examinations in asymptomatic, nonpregnant ...

USPSTF recommends CRC screening for 50- to 75-year-olds

October 6, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation ...

USPSTF: Not enough evidence to screen for OSA in asymptomatic

January 26, 2017
(HealthDay)—Current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea (OSA) in adults without any known signs or symptoms of the condition, according to a U.S. ...

USPSTF recommends BP screening for preeclampsia

September 28, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) concludes that there is a net benefit for preeclampsia screening with blood pressure measurements throughout pregnancy (B recommendation). These findings form ...

USPSTF finds evidence lacking for sleep apnea screening

June 15, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found insufficient evidence for the benefit of obstructive sleep apnea (OSA) screening in asymptomatic populations. These findings form the basis of a draft ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.